Globalization and climate change have intensified the need to address the marginalization of R&D for neglected and zoonotic diseases. We propose that drug repurposing, using enabling technologies such as artificial intelligence, can address this need at a lower cost than de novo R&D processes.
BT - Trends in Pharmacological Sciences DO - 10.1016/j.tips.2024.10.012 LA - ENG M3 - Article N2 -Globalization and climate change have intensified the need to address the marginalization of R&D for neglected and zoonotic diseases. We propose that drug repurposing, using enabling technologies such as artificial intelligence, can address this need at a lower cost than de novo R&D processes.
PB - Elsevier BV PY - 2024 T2 - Trends in Pharmacological Sciences TI - Drug repurposing for neglected and zoonotic diseases SN - 0165-6147 ER -